Clinical trials

Studies registered on ClinicalTrials.gov whose conditions were reconciled to the cancer taxonomy. Status and phase are as posted by the registrant.

89 studies match

clinicaltrialsPublishedShowing 51–89 of 89 studies · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT00880269	Efficacy and Safety of Panobinostat (LBH589) in Patients With Refractory de Novo or Secondary Acute Myelogenous Leukemia (AML)	completed	Phase 2	59	Novartis PharmaceuticalsINDUSTRY	12	Feb 23, 2017	clinicaltrials
NCT00903175	Efficacy and Safety Comparison of RAD001 Versus Sunitinib in the First-line and Second-line Treatment of Patients With Metastatic Renal Cell Carcinoma(RECORD-3)	completed	Phase 2	471	Novartis PharmaceuticalsINDUSTRY	19